These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

929 related articles for article (PubMed ID: 8935625)

  • 1. Rapid destruction of murine and human melanomas by local injection of absolute ethanol: augmentation of the anti-proliferative effects with a combination of biological response modifiers.
    Nakayama J; Toyofuku K; Kokuba H; Hori Y
    J Dermatol; 1996 Mar; 23(3):156-64. PubMed ID: 8935625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental approaches for the treatment of murine B16 melanomas of various sizes. I: Local injection of ethanol with a combination of interleukin-2 or microwaval hyperthermia for B16 melanomas with a size of less than 7 mm in diameter.
    Nakayama J; Kokuba H; Kobayashi J; Yoshida Y; Hori Y
    J Dermatol Sci; 1997 Aug; 15(2):75-81. PubMed ID: 9279687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ detection of immunocompetent cells in murine B16 melanoma locally treated with interleukin-2 or microwaval hyperthermia.
    Nakayama J; Urabe A; Terao H; Taniguchi S; Hori Y
    Pigment Cell Res; 1993 Mar; 6(2):111-6. PubMed ID: 8100634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental approaches for the treatment of murine B16 melanomas of various sizes. II: Injection of ethanol with combinations of beta-interferon and microwaval hyperthermia for B16 melanomas with a size of greater than 10 mm in diameter.
    Nakayama J; Kokuba H; Kobayashi J; Yoshida Y; Hori Y
    J Dermatol Sci; 1997 Aug; 15(2):82-8. PubMed ID: 9279688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different sensitivities of the murine melanomas BL-6 and BL-6-beta m to local injections of interleukin-2 (IL-2). Analysis of gangliosides after the treatment.
    Nakayama J; Tsuchida T; Toyofuku K; Shimokawa-Kuroki R; Taniguchi S; Hori Y
    Melanoma Res; 1994 Oct; 4(5):297-302. PubMed ID: 7858413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of murine melanoma growth with a combination of microwave hyperthermia and local injection of interleukin 2.
    Nakayama J; Urabe A; Toyofuku K; Taniguchi S; Hori Y
    Br J Dermatol; 1994 Jun; 130(6):717-24. PubMed ID: 8011496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combined therapeutic modality with hyperthermia and locally administered rIFN-beta inhibited the growth of B16 melanoma in association with the modulation of cellular infiltrates.
    Nakayama J; Toyofuku K; Urabe A; Taniguchi S; Hori Y
    J Dermatol Sci; 1993 Dec; 6(3):240-6. PubMed ID: 8136321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperthermia potentiates antitumor effect of thermosensitive-liposome-encapsulated melphalan and radiation in murine melanoma.
    Chelvi TP; Ralhan R
    Tumour Biol; 1997; 18(4):250-60. PubMed ID: 9218010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological response modifiers in melanoma.
    Bridgewater JA; Gore ME
    Br Med Bull; 1995 Jul; 51(3):656-77. PubMed ID: 7552087
    [No Abstract]   [Full Text] [Related]  

  • 10. Biochemotherapy for melanoma: rational therapeutics in the search for weapons of melanoma destruction.
    Margolin KA
    Cancer; 2004 Aug; 101(3):435-8. PubMed ID: 15274056
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anti-blastic hyperthermic perfusion in the treatment of melanoma of the extremities in the loco-regional diffusion phase].
    Di Filippo F; Garinei R; Anzà M; Cavaliere F; Botti C; Perri P; Di Filippo S
    Tumori; 2003; 89(4 Suppl):241-3. PubMed ID: 12903606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy as an adjuvant therapy in the management of advanced, surgically resected, melanoma.
    Kalani AD; Jack A; Montenegro G; Degliuomini J; Wallack MK
    G Ital Dermatol Venereol; 2008 Feb; 143(1):59-70. PubMed ID: 18833052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ["Pathomorphosis" of skin melanomas in the comprehensive treatment using hyperthermia].
    Aleksandrov NN; Neborak IuT; Furmanchuk AV; Zhavrid EA; Fradkin SZ
    Vopr Onkol; 1979; 25(1):19-26. PubMed ID: 425393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated limb perfusion with high-dose tumor necrosis factor for extremity melanoma and sarcoma.
    Fraker DL; Alexander HR
    Important Adv Oncol; 1994; ():179-92. PubMed ID: 8206489
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of locally metastatic melanoma: a novel approach.
    Shistik G; Prakash AV; Fenske NA; Glass LF
    J Drugs Dermatol; 2007 Aug; 6(8):830-2. PubMed ID: 17763615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Present status and problems in the therapy of malignant melanoma].
    Nakayama J
    Fukuoka Igaku Zasshi; 1995 Jan; 86(1):1-5. PubMed ID: 7698716
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationship between responsiveness of cancer cells to Oncostatin M and/or IL-6 and survival of stage III melanoma patients treated with tumour-infiltrating lymphocytes.
    Lacreusette A; Lartigue A; Nguyen JM; Barbieux I; Pandolfino MC; Paris F; Khammari A; Dréno B; Jacques Y; Blanchard F; Godard A
    J Pathol; 2008 Dec; 216(4):451-9. PubMed ID: 18798220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xenogeneic cell-based vaccine therapy for stage III melanoma: safety, immune-mediated responses and survival benefits.
    Seledtsova GV; Shishkov AA; Kaschenko EA; Goncharov AG; Gazatova ND; Seledtsov VI
    Eur J Dermatol; 2016 Apr; 26(2):138-43. PubMed ID: 27026566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy of metastatic malignant melanoma by a vaccine consisting of autologous interleukin 2-transfected cancer cells: outcome of a phase I study.
    Schreiber S; Kämpgen E; Wagner E; Pirkhammer D; Trcka J; Korschan H; Lindemann A; Dorffner R; Kittler H; Kasteliz F; Küpcü Z; Sinski A; Zatloukal K; Buschle M; Schmidt W; Birnstiel M; Kempe RE; Voigt T; Weber HA; Pehamberger H; Mertelsmann R; Bröcker EB; Wolff K; Stingl G
    Hum Gene Ther; 1999 Apr; 10(6):983-93. PubMed ID: 10223732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endostatin plus interferon-alpha2b therapy for metastatic melanoma: a novel combination of antiangiogenic and immunomodulatory agents.
    Moschos SJ; Odoux C; Land SR; Agarwala S; Friedland D; Volker KM; Sidor C; Wong M; Kirkwood JM
    Melanoma Res; 2007 Jun; 17(3):193-200. PubMed ID: 17505265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.